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Abstract
Background: Pulmonary tuberculosis, the most common clinical form of mycobacterial diseases, is a granulomatous 
disease of the lungs caused by Mycobaterium tuberculosis. A number of genes have been identified in studies of diverse 
origins to be important in tuberculosis. Of these, both tumor necrosis factor α (TNF-α) and lymphotoxin α (LT-α) play 
important immunoregulatory roles.
Methods: To investigate the association of TNF polymorphisms with tuberculosis in the Asian Indians, we genotyped 
five potentially functional promoter polymorphisms in the TNFA gene and a LTA_NcoI polymorphism (+252 position) of 
the LTA gene in a clinically well-defined cohort of North-Indian patients with tuberculosis (N = 185) and their regional 
controls (N = 155). Serum TNF-α (sTNF-α) levels were measured and correlated with genotypes and haplotypes.
Results: The comparison of the allele frequencies for the various loci investigated revealed no significant differences 
between the tuberculosis patients and controls. Also, when the patients were sub-grouped into minimal, moderately 
advanced and far advanced disease on the basis of chest radiographs, TST and the presence/absence of cavitary 
lesions, none of the polymorphisms showed a significant association with any of the patient sub-groups. Although a 
significant difference was observed in the serum TNF-α levels in the patients and the controls, none of the investigated 
polymorphisms were found to affect the sTNF-α levels. Interestingly, it was observed that patients with minimal 
severity were associated with lower log sTNF-α levels when compared to the patients with moderately advanced and 
far advanced severity. However, none of these differences were found to be statistically significant. Furthermore, when 
haplotypes were analyzed, no significant difference was observed.
Conclusions: Thus, our findings exclude the TNF genes as major risk factor for tuberculosis in the North Indians.
Background
Mycobacterial diseases are a major health concern, with
an estimate of approximately one-third of the world's
population being affected by them [1,2]. Pulmonary
tuberculosis, the most common clinical form of the dis-
ease, is a granulomatous disease of the lungs caused by
Mycobaterium tuberculosis. However, only 5-10% of the
infected people ever develop the disease. The genetic
contribution of the host plays a significant role in deter-
mining susceptibility to developing the active form of the
disease, the severity of infection and the health outcome
of the patient [3,4]. A number of genes have been identi-
fied in studies of diverse origins to be important in tuber-
culosis [5-7].
The genes for tumor necrosis factor-α (TNF-α; TNFA)
and lymphotoxin-α (LT-α; LTA), located within the MHC
III region of chromosome 6, shows close linkage to the
HLA class I (HLA-B) and class II (HLA-DR) genes [8].
Both TNF-α, produced mainly by monocytes and acti-
vated macrophages; and LT-α, produced mainly by acti-
vated T-cells, play important immunoregulatory roles [9].
Of these, TNF-α contributes to the pathogenesis of tuber-
culosis due to its role in the formation and maintenance
of granulomas [10]. Additionally, it also plays a major role
in host defense to M. tuberculosis by its synergistic action
with interferon-γ (IFN-γ) to activate macrophages and
thereby impacts on disease perpetuation [11,12]. Elevated
serum TNF-α (sTNF-α) levels have been reported in
advanced tuberculosis patients when compared to those
with mild tuberculosis and healthy individuals [13].
Studies on monozygotic twins and their first-degree rel-
atives, using ex vivo endotoxin stimulated whole blood
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samples, have provided evidence that 60% of variation in
the production capacity of TNF-α appears to be geneti-
cally determined [14]. Several polymorphisms within the
promoter region of TNFA and the intron 1 polymor-
phism of LTA, in particular, have been associated with
altered levels of circulating TNF-α [15,16]. A few of these
polymorphisms have been also studied for determining
susceptibility or resistance towards tuberculosis in sev-
eral ethnic groups, the results of which have been incon-
clusive [17-26].
The aim of this study was to determine associations, if
any, of potentially functional TNFA and LTA polymor-
phism(s), both individually and at the haplotype level,
with tuberculosis in patients from North-India. In addi-
tion, we have attempted to explore whether any of these
polymorphisms may be related to the severity and the
associated features of the disease. We also attempt to cor-
relate these polymorphisms with sTNF-α levels in the
patients and the controls.
Methods
Study Subjects
185 unrelated tuberculosis patients (mean age 32.16 ±
13.8 years; male:female 0.42:0.58), who presented to the
Medical Outpatient Department or were admitted at the
All India Institute of Medical Sciences hospital, New
Delhi, between 1996 and 2006 were recruited. The study
was approved by the ethical committee of the hospital
and informed consent was obtained from all participants.
Patients with chronic illness such as cirrhosis of liver,
chronic hepatitis, acute viral hepatitis, and/or gastroin-
testinal, renal, or cardiac diseases and those who were
tested positive for HIV using ELISA were excluded dur-
ing the preliminary evaluations.
Pulmonary tuberculosis
There were 149 patients in this group (Table 1). The diag-
nosis of pulmonary TB was based on the presence of
acid-fast bacilli on sputum smear or M. tuberculosis on
sputum culture. In patients with smear-positive TB, cul-
ture was not done unless multidrug- resistant TB was
strongly suspected. Sputum cultures were done in all
patients with smear-negative pulmonary TB. In patients
with negative smears and cultures (N = 17), the diagnosis
of TB was based on symptoms, chest radiographic infil-
trates in the upper lobes, and clinical and radiographic
response to antituberculosis drugs. In addition, high res-
olution computed tomography (HRCT) for the patients
showed tree-in-bud appearance compatible with the clin-
ical diagnosis of pulmonary TB. Also, all 149 pulmonary
TB patients showed a good clinical and radiographic
response to anti-TB treatment. The severity of the pul-
monary lesions was graded by studying the chest radio-
graphs following the guidelines of the American Thoracic
Society [27].
Disseminated tuberculosis
Focal disseminated tuberculosis (DTB) was diagnosed
based on the criteria including i) clinical features sugges-
tive of tuberculosis; ii) concurrent involvement of at least
two non-contiguous organ sites of the body or involve-
ment of the bone marrow; iii) microbiological and/or his-
topathological evidence of tuberculosis; (iv) evidence of
marked improvement on antituberculosis treatment. The
presence of all criteria was required for the diagnosis of
disseminated tuberculosis and there were 11 patients in
this group (Table 1). Of these, 2 patients had positive
Ziehl-Neelsen (ZN) staining on fine needle aspiration
cytology (FNAC) of the lymph nodes; 3 patients had his-
topathology of lymph nodes compatible with the diagno-
sis of TB; 4 patients had both positive ZN staining and
Mycobacterium tuberculosis (Mtb) culture positivity in
the pus from cold abscess and additional 2 patients had
only Mtb culture positivity. All patients showed a good
clinical response to anti-TB treatment.
Lymph node tuberculosis
Lymph node tuberculosis (LNTB) was diagnosed based
on the following criteria i) clinical presentation compati-
ble with tuberculosis; ii) fine needle aspiration cytology
presenting evidence of tuberculosis with positive staining
for acid-fast bacilli; iii) histopathological evidence of
caseating granulomas on lymph node biopsy specimens;
iv) evidence of marked improvement on antituberculosis
treatment. The presence of i), and either ii) or iii) and iv)
was required for the diagnosis of lymph node tuberculo-
sis and there were 25 patients in this group (Table 1). Of
these, 7 patients had positive ZN staining on FNAC and
20 had histopathology of the lymph nodes compatible
with the diagnosis of tuberculosis of the lymph nodes (2
of these also had positive FNAC). All these patients
showed a good clinical response to anti-TB treatment.
Normal Controls
Healthy Volunteers (referred to as normal controls, N =
155; mean age 28.16 ± 13.6 years; male:female 0.46:0.54)
were randomly recruited from the general population
with the same socio-economic status and ethnic back-
ground as that of the patients. All individuals gave
informed consent and were screened negative for HIV
infection and a family history of tuberculosis or any other
related disease. In addition, these individuals had a nega-
tive tuberculin test (to exclude a possibility of a latent
tuberculosis infection) and their chest radiographs as well
as peripheral blood counts and blood chemistries were
normal.
All patients with TB and normal controls recruited for
the study represented a fairly homogeneous ethnic group
of north Indian Hindu population from the states of Pun-
jab, Haryana, Uttar Pradesh and Delhi. All these individu-
als come under the Indo-European linguistic group and
belong to the same ethnic group (group 1) [28,29].
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Tuberculin Skin Test (TST)
The TST was done using 5 tuberculin purified protein
derivative (PPD) units (5 TU Tuberculin PPD/0.1 ml;
Span Diagnostics Ltd., India); and the indurations were
measured after 48 hours. A cut-off of 10 mm was used for
a positive TST.
Serum TNF-α measurement
Serum TNF-α levels were determined for 107 tuberculo-
sis patients and 112 normal controls using the OPTEIA™
ELISA kit (BD Biosciences), as per the manufacturer's
instruction.
Genotyping
Isolation of the genomic DNA from the peripheral blood
leukocytes was carried out using the modified salting out
procedure as described elsewhere [16]. Polymorphisms in
the TNF genes, namely TNFA-1031T > C, TNFA-863C >
A, TNFA-857T > C, TNFA-308G > A, TNFA-238G > A
and the LTA_NcoI polymorphism were genotyped using
primer pairs as described elsewhere [16]. Briefly, the
TNFA-1031T > C, TNFA-863C > A, TNFA-857T > C,
TNFA-308G > A and the TNFA-238G > A were studied
using SNaPshot ddNTP Primer Extension Kit (Applied
Biosystems, Foster City, USA) as per the manufacturer's
instructions. To clean up the primer extension reaction,
1U of calf intestinal phosphatase (CIP) (New England
Biolabs) was added to the reaction mixture and the mix-
ture was incubated at 37°C for 1 hour, followed by 15
minutes at 72°C for enzyme inactivation. These samples
were subsequently electrophoresed using the ABI Prism
3100 Genetic Analyzer as per the manufacturer's instruc-
tions. The results were analyzed using the GeneMapper
software (Applied Biosystems, Foster City, USA). The
LTA_NcoI polymorphism was assessed using NcoI
restriction endonuclease digestion. The accuracy of geno-
typing was confirmed by direct sequencing of the DNA
samples (N = 5) for all three respective genotypes for all
the loci investigated.
Statistical Analysis
The allele frequencies were calculated and agreement
with Hardy-Weinberg equilibrium was tested using a χ2
goodness-of-fit test for each locus. The association
between two categorical variables was evaluated by likeli-
hood ratio (LR) χ2 and Fishers exact tests. All statistical
tests performed were two-tailed. ANOVA was performed
to test the effect of the polymorphisms and haplotypes on
sTNF-α levels and F-ratio statistics were calculated to
study the variation in sTNF-α levels in different groups.
PHASE was used to infer haplotypes for each individual
[30]. Clump22 software was used with 1,000,000 Monte-
Carlo simulations to determine the primary difference in
the haplotype frequencies [31]. Normal (T1) χ2 values,
calculated from the 2 × N raw data, and maximum (T4) χ2
values, calculated by simulating 2 × N data followed by
clumping into 2-by-2 tables to produce maximal chi-
squared values, have been reported.
Results
Association of TNF polymorphisms with tuberculosis
The genotype frequencies for all the polymorphisms
investigated did not deviate significantly from Hardy-
Weinberg expectations in both the patient and the con-
trol populations (p > 0.05). Table 2 and Table 3 enlist the
allele and the genotype frequencies for all the polymor-
phisms genotyped in the TNF genes, respectively. The
comparison of the allele and genotype frequencies for all
Table 1: Clinical characteristics of the tuberculosis patients used for the study
PTB DTB LNTB
No. of patients 149 11 25
Age (years; ± SD) 32.50 ± 13.3 34.36 ± 12.9 29.12 ± 11.6
Sex (M:F) 0.37:0.63 0.27:0.73 0.76: 0.24
Sputum smear 129 0 0
Sputum culture 47 0 0
Lymph node FNAC ND 2 7
Lymph node biopsy ND 3 20
Pus smear ND 4 0
Pus culture ND 6 0
Positive TST response 79 8 17
Response to treatment 149 11 25
Some patients in the PTB group had both smears and cultures positive while in the LNTB group, two patients had positive FNAC as well as 
biopsy positive. Similarly, in the DTB group 4 patients had both smear and cultures positive from the cold abscesses.
DTB: disseminated tuberculosis; PTB: pulmonary tuberculosis; LNTB = lymph node tuberculosis; FNAC= fine needle aspiration cytology
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the loci investigated revealed no significant differences
between the tuberculosis patients and controls (p > 0.05;
Table 2 and Table 3, respectively).
Association of TNF polymorphisms in tuberculosis sub-
groups
The severity of the pulmonary lesions was graded by
studying the chest radiographs following the guidelines of
the American Thoracic Society [27]; the patients were
sub-grouped into minimal, moderately advanced and far
advanced. Further, the patients were also sub-grouped on
the basis of response to TST (negative/positive) and the
presence/absence of cavitary lesions. However, none of
the studied polymorphisms showed a significant associa-
tion with any of the patient sub-groups (p > 0.05; data not
shown).
Association of TNF haplotypes with tuberculosis
To study the combined effects of the six SNPs in the TNF
genes, haplotypes were estimated by the statistical soft-
ware PHASE. Of the 13 haplotypes observed in the 185
TB patients and 155 controls recruited for the study, only
five haplotypes were represented at frequencies >5% (Fig-
ure 1). These accounted for >87% of the total haplotypes.
As the count per haplotype was very low, Clump22 with
1,000,000 Monte-Carlo simulations was used to estimate
differences in the haplotype frequencies in the patients
and controls. However, no significant differences were
observed in the haplotype counts in the two groups [nor-
mal (T1) χ2 = 18.498, df = 12, P = 0.78; and maximum
(T4) χ2 = 7.825, P = 0.214]. Therefore, it may be con-
cluded that haplotypes in the TNF genes were not associ-
ated with tuberculosis in the studied population.
Association analyses of TNF polymorphisms with its serum 
levels
TNF-α levels were measured in the serum samples of 107
tuberculosis patients and 112 unrelated controls. A dif-
ference with borderline significance was observed in the
serum TNF-α levels in the patients and the controls (F-
ratio = 3.84, df = 1, p = 0.051); a higher levels of the
cytokine was observed in the patients sera [log sTNF-α ±
standard deviation (s.d.) = 1.89 ± 0.87] when compared
with the control population [log sTNF-α ± s.d. = 1.65 ±
0.89].
Although, none of the investigated polymorphisms
were found to affect the sTNF-α levels in both the patient
and the control populations and in the patient sub-groups
(p > 0.05), a few interesting observations were made. Of
the 107 patients, 39 patients with positive TST showed
higher log sTNF-α levels (2.10 ± 0.91) while 68 patients
with negative TST showed lower log sTNF-α levels (1.75
± 0.84) [F-ratio = 3.92, df = 1, p = 0.05]. Furthermore,
when the patients were graded on the basis of severity
into minimal severity, moderately advanced and far
advanced sub-groups, it was observed that patients with
minimal severity had lower log sTNF-α levels (1.54 ±
Table 2: Allele frequencies of the polymorphisms investigated in the TNFA and LTA genes. 





NcoI A 270 (72.97) 244 (78.71) 0.09
G 100 (27.03) 66 (21.29)
-1031 C 136 (36.76) 110 (35.48) 0.79
T 234 (63.24) 200 (64.52)
-863 A 119 (32.16) 100 (32.26) >0.99
C 251 (67.84) 210 (67.74)
-857 C 339 (91.62) 276 (89.03) 0.29
T 31 (8.38) 34 (10.97)
-308 A 36 (9.73) 27 (8.71) 0.69
G 334 (90.27) 283 (91.29)
-238 A 23 (6.22) 14 (4.52) 0.40
G 347 (93.78) 296 (95.48)
Numbers in parentheses indicate the frequency (%).
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0.73) when compared to the patients with moderately
advanced (1.86 ± 0.98) and far advanced severity (1.96 ±
0.71). However, none of these differences were statisti-
cally significant (p > 0.05). Additionally, no difference was
observed in the log sTNF-α levels when patients were
sub-grouped on the basis of presence/absence of cavitary
lesions in the X-rays (p > 0.05).
Furthermore, when haplotypes (counts ≥ 2) were ana-
lyzed with respect to sTNF-α levels in the patient samples
(case-only analysis), no significant difference were
observed (p-value > 0.05), thereby negating the influence
of any of the studied polymorphisms on sTNF-α levels in
the study population.
Discussion
TNF-α plays an important role in granuloma formation
in tuberculosis. Previous studies have shown that mice
deficient in TNF-α exhibit poorly formed granulomas
with areas of extensive necrosis, resulting in widespread
dissemination of M. tuberculosis and rapid death of ani-
mals [32]. Earlier data obtained from the rheumatoid
arthritis patients treated with TNF-α antagonists showed
that blocking TNF-α could lead to reactivation of tuber-
culosis [33]. All these points hint towards TNFA as an
important candidate gene for tuberculosis.
The promoter region of the TNFA gene is highly poly-
morphic. In this case-control study, conducted in tuber-
culosis patients and normal controls recruited from
Northern India, we focused on potential functional poly-
morphisms in the transcriptional region of TNFA and a
LTA_NcoI (+252) polymorphism in the first intron of LTA
gene a few of which have earlier been associated with
TNF-α levels [15,16]. Individually, none of the polymor-
phisms showed any significant association with tubercu-
losis or sTNF-α levels. An earlier study carried out in
HLA-A, B and DR typed pulmonary tuberculosis patients
(N = 210) and healthy control subjects (N = 120) from
South India also failed to detect any significant differ-
ences between the LTA_NcoI and TNFA_-308 and
TNFA_-238 polymorphisms and tuberculosis [20]. These
Table 3: Genotype frequencies of the polymorphisms investigated in the TNFA and LTA genes. 






NcoI AA 94 (50.81) 97 (62.58) 3.43
AG 82 (44.32) 50 (32.26) 0.18
GG 9 (4.86) 8 (5.16)
-1031 CC 25 (13.51) 20 (12.90) 0.13
CT 86 (46.49) 70 (45.16) 0.94
TT 74 (40.0) 65 (41.94)
-863 AA 17 (9.19) 17 (10.97) 0.53
AC 85 (45.95) 66 (42.58) 0.77
CC 83 (44.86) 72 (46.45)
-857 CC 154 (83.24) 123 (79.35) NC
CT 31 (16.76) 30 (19.35) NS
TT 0 (0) 2 (1.29)
-308 AA 3 (1.62) 2 (1.29) NC
AG 30 (16.22) 23 (14.84) NS
GG 152 (82.16) 130 (83.87)
-238 AA 2 (1.08) 0 (0) NC
AG 19 (10.27) 14 (9.03) NS
GG 164 (88.65) 141 (90.97)
Numbers in parentheses indicate the frequency (%).
df: Degrees of freedom; NC - Test not conducted as counts are less than 5 for a few categories; NS - Non-significant.
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included active and cured tuberculosis patients as well as
controls of Indo-dravidian origin, an ethnicity different
from ours, recruited from North-India and belonging to
the Indo-European linguistic group. Additionally, another
recent study carried out in the north-Indian populations
also failed to find any association of TNFA -308 promoter
polymorphism with tuberculosis [34]. This study was
conducted in ethnically matched 145 physician diagnosed
tuberculosis patients and 211 normal healthy controls
recruited from the state of Punjab from North India.
However, in both these studies no attempts were made to
correlate these and the other promoter polymorphisms
individually and at the level of haplotype with sTNF-α
levels. Also, the normal controls recruited for our study
were tested negative by the TST test and had normal
blood chemistries, peripheral blood counts and normal
chest radiographs. Additionally, all patients and controls
recruited for our study were HIV-negative. Our study
also gains support from others which report a lack of
association between TNF gene polymorphisms and
tuberculosis in different populations (Table 4). On the
other hand, a few studies reported association between
the TNFA_-308 polymorphism and tuberculosis [22,35-
37]. However, these differences in results could be attrib-
uted to ethnic variations that persist in different popula-
tions, study design and patient selection criteria.
Additionally, the association observed in the later studies
may be explained on the basis of linkage disequilibrium
that exists between the TNF genes and HLA [38].
Our study also failed to detect any effect of the TNF
polymorphisms on sTNF-α levels in the tuberculosis
patients. The results from previous in vivo and in vitro
studies conducted for the TNFA-308G > A polymor-
phism have rather been conflicting. Whereas there are
studies which report the minor TNFA-308A allele (allele
2) to be associated with higher inducible levels of gene
transcription and TNF-α production [39,40], our earlier
study in sarcoidosis patients found the G allele for this
polymorphism to be associated with high sTNF-α levels
[16]. It is also evident from the study by Knight et al that
the TNFA-308 SNP does not regulate TNF-α levels and is
not likely to be the functionally important SNP as previ-
ously hypothesized [41]. Thus, it may be possible that
another SNP in LD is involved in this phenomenon. Fur-
Figure 1 The frequency distribution of the haplotypes of the TNFA and LTA genes. The frequency distribution of the haplotypes of the TNFA and 
LTA genes in tuberculosis patients (dark bars) and unrelated controls (light bars). The haplotypes have been plotted on the x-axis and their respective 























































Table 4: Association studies of the TNF genes with tuberculosis.
S. No Reference Polymorphisms 
Investigated
Location Population Sample size Results




South Indian 210 PTB patients and 120 normal 
controls (NC)
No association with pulmonary 
TB (PTB).
2. Ates et al. [17] TNFA -308 G/A, -238 G/A, -
376 G/A
Promoter Turkish 128 TB patients and 80 NC No association with TB.
3. Vejbaesya et al. [21] TNFA +488, -238, and -308 Promoter Thai 149 TB patients and 147 NC No association with TB.
4. Amirzargar et al. [37] TNFA -308, G/A -238 Promoter Iranian 41 PTB and 123 NC -238 polymorphism was 
associated with pulmonary TB 
(p = 0.0009).
5. Shaw et al. [42] Linkage study Markers 
across the 
genome
Northern Brazilian 98 pedigrees, with 704 individuals Minor role of TNFA in control of 
TB.
6. Correa et al. [35,36] TNFA -308, G/A -238 Promoter Columbia 138 TB and 419 NC Association of TNF1 with TB (OR: 
1.9, 95%C.I. 1.2-3.1, p = 0.02)
7. Wu et al. [24] TNFA -308 Promoter Chinese 61 PTB patients and 122 PTB-free 
miners.
Lack of association with TB.
8. Larcombe et al. [26] TNFA -308 Promoter Canadian Aboriginal Three cohorts n = 61, 42 and 91 for 
Dené, Cree and healthy Caucasians, 
respectively
Lack of association with TB.
9. Henao et al. [25] TNFA -308 Promoter Colombian 54 tuberculin-negative NC, 81 
tuberculin-positive NC, 140 PTB 
patients, 30 with pleural TB and 20 
with miliary TB
Lack of association with TB.
10. Kumar et al. [34] TNFA -308 Promoter Indian 145 TB and 211 NC Lack of association with TB.
11. Oh et al. [18] TNFA -308 Promoter Korean 117 NC, 80 newly diagnosed TB 
patients and 65 patients with 
recurrent TB
TNFA gene does not affect 
differential TB susceptibility.




North Indian 185 TB patients and 155 NC Lack of association with TB.
PTB = pulmonary tuberculosis; NC = normal controls
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ther high resolution HLA typing data in addition to fine
mapping of the TNF genes would be of help in resolving
these problems.
To enhance our understanding about the contribution
of these genetic variants further to tuberculosis, six-locus
haplotypes were constructed and their distribution was
compared in the patients and the control population.
None of the haplotype showed significant association
with tuberculosis in the study population.
Conclusions
In summary, our findings suggest that the polymor-
phisms present in and around the TNF genes are unlikely
to be the major risk factors for tuberculosis in Asian Indi-
ans. However, as the present study was performed with
relatively small sample size, further studies with larger
sample sizes would be necessary to elucidate the role of
TNF polymorphisms in tuberculosis.
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